Thymic carcinoma historical perspective

Thymic Carcinoma Microchapters
Home
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Thymic carcinoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
Echocardiograph and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Future or Investigational Therapies
Case Studies
Case #1
Thymic carcinoma historical perspective On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Google Images
American Roentgen Ray Society Images of Thymic carcinoma historical perspective All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Thymic carcinoma historical perspective
CDC on Thymic carcinoma historical perspective
Thymic carcinoma historical perspective in the news
Blogs on Thymic carcinoma historical perspective
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Thymic carcinoma historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Marjan Khan M.B.B.S.[2]

Overview

The thymic epithelial tumor staging system was initially proposed by Bergh and his colleagues in 1978,modified by Wilkins and Castleman in 1979, and further developed by Masaoka et al. in 1981.